New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.
Health News is provided as a service to American Surgical Pharmacy site users by HealthDay. American Surgical Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.